Urocortin inhibits mesenteric arterial remodeling in spontaneously hypertensive rats

Peptides

Volumn 30, Issue 6, 2009, Pages 1117-1123

  Chen, Jiandong ^a,b   Tao, Jin ^a,c   Zhang, Rongjian ^a   Xu, Youhua ^a   Soong, TuckWah ^d   Li, Shengnan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Arterial remodeling; Spontaneously hypertensive rats; Urocortin

Indexed keywords

ACETYLCHOLINE; ENALAPRIL; NORADRENALIN; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ELECTRON MICROSCOPY; HEART PROTECTION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TRANSMISSION ELECTRON MICROSCOPY;

ACETYLCHOLINE; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; MESENTERIC ARTERIES; MICROSCOPY, ELECTRON; NOREPINEPHRINE; RATS; RATS, INBRED SHR; TIME FACTORS; UROCORTINS;

RATTUS;

EID: 67349248601     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.02.014     Document Type: Article

References (35)

1. Allen M.P., Zeng C., Schneider K., Xiong X., Meintzer M.K., and Bellosta P. Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol 13 (1999) 191-201
2. Baumbach G.L., and Heistad D.D. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13 (1989) 968-972
3. Brar B.K., Jonassen A.K., Stephanou A., Santilli G., Railson J., Knight R.A., et al. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 275 (2000) 8508-8514
4. Bund S.J., West K.P., and Heagerty A.M. Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and wistar-kyoto rats. Circ Res 68 (1991) 1230-1240
5. Chalmers D.T., Lovenberg T.W., and De Souza E.B. Localization of novel corticotropin-resealing factor receptor (CRF2) mRNA repression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15 (1995) 6340-6350
6. Cobb M.H., and Goldsmith E.J. How MAP kinases are regulated. J Biol Chem 270 (1995) 14843-14846
7. Deng L.Y., and Schiffrin E.L. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci 88 (1995) 611-622
8. Donaldson C.J., Stutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., and Rivier J.E. Cloning and characterization of human urocortin. Endocrinology 137 (1996) 2167-2170
9. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10 (1998) 262-267
10. Fisher L.A., Jessen G., and Brown M.R. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate. Regul Peptides 5 (1983) 153-161
11. Furuyama M. Histometrical investigations of arteries in reference to arterial hypertension. J Exp Med 76 (1962) 388-414
12. Huang Y., Chan F.L., and Lau C.W. Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels. Br J Pharmacol 135 (2002) 1467-1476
13. Jain V., Vedernikov Y.P., Saade G.R., Chwalisz K., and Garfield R.E. Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J Pharmacol Exp Ther 288 (1999) 407-413
14. Ledingham J.M., Phelan E.L., Cross M.A., and Laverty R. Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically of chronic treatment with valsartan, enalapril and felodipine. Vasc Res 37 (2000) 134-145
15. Lei S., Richter R., Bienert M., and Mulvany M.J. Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 108 (1993) 941-947
16. Leitch I.M., Boura A.L., Read M.A., Walters W.A., and Smith R. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 83 (1998) 4510-4513
17. Liu C.N., Yang C., Liu X.Y., and Li S. In vivo protective effects of urocortin on ischemia/reperfusion injury in rat heart via free radical mechanisms. Can J Physiol Pharmacol 83 (2005) 459-465
18. Lovenberg T.W., Chalmers D.T., Liu C., and De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136 (1995) 4139-4142
19. Lubomirov L., Gagov H., and Petkova-Kirova. Urocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calcium. Br J Pharmacol 134 (2001) 1564-1570
20. Luscher T.F., Aarhus L.L., and Vanhoutte P.M. Indomethacin improves the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rat. Am J Hypertens 3 (1990) 55-58
21. Mulvany M.J., and Hansen P.K. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 43 (1978) 854-864
22. Mulvany M.J., and Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41 (1977) 19-26
23. Parkes D.G., Vaughan J., River J., Vale W., and May C.N. Inotropic actions of urocortin in conscious sheep. Am J Cardiac Physiol 272 (1997) H2115-H2122
24. Pisarchik A., and Slominski A.T. Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15 (2001) 2754-2756
25. Rademaker M.T., Charles C.J., Espiner E.A., Fisher S., Frampton C.M., and Kilkpatrick C.M. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Cell Cardiol 40 (2002) 1495-1505
26. Schilling L., Kanzler C., Schmiedek P., and Ehrenreih H. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. Br J Pharmacol 125 (1998) 1164-1171
27. Semda J.S., Lee R.M., and Forrest J.B. Prenatal and postnatal hydralazine treatment doses does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res 63 (1998) 534-542
28. Short D. The vascular fault in chronic hypertension with particular reference to the role of medial hypertrophy. Lancet 1 (1966) 1302-1304
29. Slominski A., Roloff B., Curry J., Dahiya M., Szczesniewski A., and Wortsman J. The skin produces urocortin. J Clin Endocrinol Metab 85 (2000) 815-823
30. Smagin G.N., Howell L.A., Ryan D.H., and De Souza E.B. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport 9 (1998) 1601-1606
31. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., and Vale W. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273 (1996) 1561-1564
32. Tao J., Chen J., Wu Y., and Li S. Urocortin reduces the viability of adult rat vascular smooth muscle cells via inhibiting L-type calcium channels. Peptides 26 (2005) 2239-2245
33. Tao J., Zhang Y., Soong T.W., and Li S. Urocortin 2 inhibits the apoptosis of mesenteric arterial smooth muscle cells via L-type calcium channels in spontaneously hypertensive rats. Cell Physiol Biochem 17 (2006) 111-120
34. Thybo N.K., Stephens N., Cooper A., Aalkjaer C., Heagerty A.M., and Mulvany M.J. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 25 (1995) 474-481
35. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., and Lewis K. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 78 (1995) 287-292